Table 2.
Results on the comparative effectiveness of the interventions from the network and pairwise meta-analyses
| Combination | 0.18 (−0.20 to 0.55) (N=1; I2=NA*) |
−0.13 (−0.63 to 0.36) (N=4, I2=41%) |
NA† |
| −0.00 (−0.33 to 0.33) (N=21; I2=46%) |
Exercise | −0.08 (−0.29 to 0.12) (N=3; I2=0%) |
−0.58 (−1.14 to −0.01) (N=6; I2=69%) |
| −0.12 (−0.40 to 0.16) (N=21; I2=46%) |
−0.12 (−0.33 to 0.10) (N=21; I2=46%) |
Antidepressants | −0.33 (−0.49 to −0.16) (N=11; I2=38%) |
| −0.45 (−0.76 to −0.14) (N=21; I2=46%) |
−0.45 (−0.67 to −0.23) (N=21; I2=46%) |
−0.33 (−0.48 to −0.19) (N=21; I2=46%) |
Control |
Results of the network meta-analyses are presented in grey and results of the pairwise meta-analyses are presented in white. Estimates are displayed as column versus row for the network meta-analyses and row versus column for the pairwise meta-analyses. Results are expressed as standardised mean differences (SMD). A negative SMD indicates a superiority of the first treatment over the comparison treatment.
*No evidence on I2 is available as there was only one study for that comparison.
†No studies compared combination treatment versus no treatment.
N, number of studies in the comparison; NA, not available.